What Our Analysts Know About Salesforce

By Harris Dyer • Friday, January 12 09:48 • Permanent Link

Large-cap Technology company Salesforce has moved 1.1% so far today on a volume of 658,296, compared to its average of 5,423,193.

Salesforce trades 7.67% away from its average analyst target price of $254.73 per share. The 43 analysts following the stock have set target prices ranging from $143.35 to $336.21, and on average have given Salesforce a rating of buy.

Anyone interested in buying CRM should be aware of the facts below:

Salesforce's current price is 1539.5% above its Graham number of $16.73, which implies that at its current valuation it does not offer a margin of safety
Salesforce has moved 81.5% over the last year, and the S&P 500 logged a change of 19.5%
Based on its trailing earnings per share of 2.63, Salesforce has a trailing 12 month Price to Earnings (P/E) ratio of 104.3 while the S&P 500 average is 15.97
CRM has a forward P/E ratio of 31.5 based on its forward 12 month price to earnings (EPS) of $8.72 per share
The company has a price to earnings growth (PEG) ratio of 1.49 — a number near or below 1 signifying that Salesforce is fairly valued compared to its estimated growth potential
Its Price to Book (P/B) ratio is 4.58 compared to its sector average of 7.92
Salesforce, Inc. provides Customer Relationship Management (CRM) technology that brings companies and customers together worldwide.
Based in San Francisco, the company has 70,843 full time employees and a market cap of $265.5 Billion.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.